Dialysis News and Research

Latest Dialysis News and Research

Fresenius Medical Care's Patient Travel Service to provide free dialysis scheduling assistance to travelling patients

As thousands of people plan getaways for the fall and winter travel seasons, easy access to healthcare is a concern for many travelers with chronic health conditions who require life-sustaining treatments. Twenty-six million Americans suffer from chronic kidney disease, and more than 355,000 of them require dialysis every few days to stay alive.

24 Aug 2009

Night home hemodialysis offers similar benefits as kidney transplants

For the first time, it has been shown that patients who receive night home hemodialysis live just as long as those who receive kidney transplants from deceased donors.

21 Aug 2009

Illegal immigrant dialysis in Las Vegas costly to hospitals, system

The Las Vegas Review-Journal reports that dialysis care for illegal immigrants at a taxpayer-supported medical center costs $20 million a year and that the immigrants are being referred there from for-profit hospitals.

21 Aug 2009

New portable dialysis machine that provides continuous dialysis is under development

Researchers are developing a Wearable Artificial Kidney for dialysis patients, reports an upcoming paper in the Clinical Journal of the American Society of Nephrology (CJASN). "Our vision of a technological breakthrough has materialized in the form of a Wearable Artificial Kidney, which provides continuous dialysis 24 hours a day, seven days a week," comments Victor Gura, MD (David Geffen School of Medicine at UCLA).

21 Aug 2009

Proposed Federal budget cuts will put seniors at risk

The Health Facilities Association of Maryland (HFAM) today brought together U.S. Representative Frank Kratovil (MD-1) and residents, workers and leaders from the Salisbury Rehabilitation and Nursing Center to personalize the pending effects of a proposed $32 billion federal cut to Medicare.

20 Aug 2009

Study reveals that patient care is better in nonprofit nursing homes than in for-profit nursing homes

A major new statistical review of 82 individual research studies has revealed that nonprofit nursing homes deliver, on average, higher quality care than for-profit nursing homes. The findings could have a bearing on the present debate about the role of for-profit firms in U.S. health reform.

20 Aug 2009

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.

19 Aug 2009

Genetic mutation that helps regulate high blood pressure is a cause of inherited kidney disease

The discovery provides insight into a protein, renin, that is important in blood pressure regulation, and reveals the cause of one type of inherited kidney disease occurring in adults and children, said co-investigator Anthony Bleyer, M.D., professor of internal medicine-nephrology at the School of Medicine.

19 Aug 2009

Cancer Institute of New Jersey expands hospital network

Enhancing its strong presence as a statewide leader in cancer care and providing patients with additional access to cancer programs, The Cancer Institute of New Jersey (CINJ) Network of hospitals has formally welcomed Mountainside Hospital as its newest Clinical Research Affiliate.

12 Aug 2009

FDA approves APP Pharmaceuticals' Idarubicin HCI injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.

10 Aug 2009

Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. has announced today that Soliris® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). AHUS is an ultra-rare, inherited, and life-threatening complement-inhibitor deficiency disease that often progresses to end-stage kidney disease or failure. The U.S. Food and Drug Administration granted orphan drug designation to Soliris for the same indication in May 2009. Soliris is not approved for the treatment of patients with aHUS.

6 Aug 2009

Therapeutic hypothermia after cardiac arrest is cost-effective

A brain-preserving cooling treatment called therapeutic hypothermia is a cost-effective way to improve outcomes after out-of-hospital cardiac arrest, which claims the lives of more than 300,000 people each year in the United States and leaves thousands of others neurologically devastated.

6 Aug 2009

Cooling unconscious cardiac arrest survivors increases survival, cost effective

Cooling unconscious cardiac arrest survivors can increase survival and has a cost effectiveness comparable to other widely accepted treatments in modern health care, researchers report in Circulation: Cardiovascular Quality and Outcomes.

4 Aug 2009

Carbon nanosensor sniffs out kidney disease

A carbon nanosensor “electronic nose” - first developed by Technion-Israel Institute of Technology researchers to detect cancer from breath samples - has been modified to identify chronic renal failure (CRF).

4 Aug 2009

'Urine NGAL' gives clues to kidney injury in ICU patients and HIV-related kidney disease

Acute kidney injury (AKI) is a frequent complication in patients in intensive care. A new laboratory test called urine neutrophil gelatinase associated lipocalin (NGAL) helps predict if patients will develop acute kidney injury, reports an upcoming study in the Journal of the American Society of Nephrology (JASN).

26 Jul 2009

Fresh meats often contain additives harmful to kidney disease patients

Uncooked meat products enhanced with food additives may contain high levels of phosphorous and potassium that are not discernable from inspection of food labels, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). This can make it difficult for people to limit dietary phosphorous and potassium that at high levels are harmful to kidney disease patients.

26 Jul 2009

Dialysis treatments OK for patients who have had a heart attack

Dialysis treatments do not affect the heart health of kidney disease patients who have had a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Since cardiovascular disease is the most common cause of death in kidney disease patients, the findings are good news for individuals who need the treatments.

9 Jul 2009

Combining two common medical tests provides new way to screen for serious kidney disease

The combination of two common medical tests can improve a doctor's ability to predict which patients will develop serious kidney disease, a research team led by the Norwegian University of Science and Technology (NTNU) reports in a recent issue of the Journal of the American Society of Nephrology.

7 Jul 2009

For America's aged, surgery at any price?

When doctors decide whether or not to go ahead with an expensive surgery, "age is no longer the deciding factor, even for invasive treatment such as open-heart surgery," The Philadelphia Inquirer reports.

7 Jul 2009

1 in 7 Australians over 25 have chronic kidney disease

The latest report from the Australian Institute of Health and Welfare (AIHW) says between 2006 and 2007 more than a million hospital admissions in Australia were due to chronic kidney disease which was also a contributing factor in one in 10 deaths in 2006.

26 May 2009

Dialysis News and Research

Latest Dialysis News and Research

Fresenius Medical Care's Patient Travel Service to provide free dialysis scheduling assistance to travelling patients

Night home hemodialysis offers similar benefits as kidney transplants

Illegal immigrant dialysis in Las Vegas costly to hospitals, system

New portable dialysis machine that provides continuous dialysis is under development

Proposed Federal budget cuts will put seniors at risk

Study reveals that patient care is better in nonprofit nursing homes than in for-profit nursing homes

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Genetic mutation that helps regulate high blood pressure is a cause of inherited kidney disease

Cancer Institute of New Jersey expands hospital network

FDA approves APP Pharmaceuticals' Idarubicin HCI injection

Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome

Therapeutic hypothermia after cardiac arrest is cost-effective

Cooling unconscious cardiac arrest survivors increases survival, cost effective

Carbon nanosensor sniffs out kidney disease

'Urine NGAL' gives clues to kidney injury in ICU patients and HIV-related kidney disease

Fresh meats often contain additives harmful to kidney disease patients

Dialysis treatments OK for patients who have had a heart attack

Combining two common medical tests provides new way to screen for serious kidney disease

For America's aged, surgery at any price?

1 in 7 Australians over 25 have chronic kidney disease

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Dialysis News and Research

Latest Dialysis News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in